Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongkun Sun

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|July 22, 2025
Central vs. Peripheral Venous Oxaliplatin Administration and Chemotherapy-Induced Peripheral Neuropathy SeverityTingting Yang, Yuting Fang, Lixia Chang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 10, 2015
Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancerYihebali Chi, Jianliang Yang, Sheng Yang, et al.
IEEE Transactions on Neural Networks and Learning Systems|August 20, 2019
Disturbance Observer-Based Neural Network Control of Cooperative Multiple Manipulators With Input SaturationWei He, Yongkun Sun, Zichen Yan, et al.
Journal of Advanced Research|March 16, 2026
Ion channels in macrophages: dynamic regulation in cardiovascular and cerebrovascular diseases and therapeutic potentialXiangqin Tian, Yangyang Jia, Changye Sun, et al.
Journal of Hematology & Oncology|January 16, 2019
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumorsYongkun Sun, Lin Yang, Xuezhi Hao, et al.
Frontiers of Medicine|October 14, 2025
Precision medicine for advanced biliary tract cancer in China: current status and future perspectivesZhen Huang, Wen Zhang, Yongkun Sun, et al.
Drug Design, Development and Therapy|November 27, 2025
Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II StudyWenwei Yang, Jing Zhang, Guifu Wu, et al.
BMC Gastroenterology|April 17, 2025
Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinomaWenjie Liu, Yuting Fang, Chao Zhang, et al.
British Journal of Cancer|October 25, 2024
Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative studyBaoqi Li, Wenwei Yang, Na Liu, et al.
BMC Gastroenterology|March 16, 2017
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in ChinaYuelu Zhu, Yongkun Sun, Shangying Hu, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|July 22, 2025
Central vs. Peripheral Venous Oxaliplatin Administration and Chemotherapy-Induced Peripheral Neuropathy SeverityTingting Yang, Yuting Fang, Lixia Chang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 10, 2015
Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancerYihebali Chi, Jianliang Yang, Sheng Yang, et al.
IEEE Transactions on Neural Networks and Learning Systems|August 20, 2019
Disturbance Observer-Based Neural Network Control of Cooperative Multiple Manipulators With Input SaturationWei He, Yongkun Sun, Zichen Yan, et al.
Journal of Advanced Research|March 16, 2026
Ion channels in macrophages: dynamic regulation in cardiovascular and cerebrovascular diseases and therapeutic potentialXiangqin Tian, Yangyang Jia, Changye Sun, et al.
Journal of Hematology & Oncology|January 16, 2019
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumorsYongkun Sun, Lin Yang, Xuezhi Hao, et al.
Frontiers of Medicine|October 14, 2025
Precision medicine for advanced biliary tract cancer in China: current status and future perspectivesZhen Huang, Wen Zhang, Yongkun Sun, et al.
Drug Design, Development and Therapy|November 27, 2025
Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II StudyWenwei Yang, Jing Zhang, Guifu Wu, et al.
BMC Gastroenterology|April 17, 2025
Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinomaWenjie Liu, Yuting Fang, Chao Zhang, et al.
British Journal of Cancer|October 25, 2024
Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative studyBaoqi Li, Wenwei Yang, Na Liu, et al.
BMC Gastroenterology|March 16, 2017
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in ChinaYuelu Zhu, Yongkun Sun, Shangying Hu, et al.
Pageof 8